510(k) Report

510(k) · Cleared

Cleared

Delta T

K041076510(k) SpecialCleared Aug 9, 2004105-day reviewClass II21 CFR 868.5880

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Penlon, Ltd. · CAD Vaporizer, Anesthesia, Non-Heated

Cleared on Aug 9, 2004 after a 105-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Aug 9, 2004
Review
105 days
Class
Class II
Product code
CAD
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K041076Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAD device

  1. #1 K240375 V80 Anesthetic Vaporizer (V80)score 8.9 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All CAD devices

CAD Vaporizer, Anesthesia, Non-Heated: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAD

1in 2024

2011: 12015: 12018: 12024: 1
2007high 1 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAD

Too few CAD 510(k)s in any year since 2007 to give a median.

Recalls per year · CAD

2in 2025

2024: 52025: 2, 2 Class I
2007high 5 (2024) · low 0 (2007)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAD

2,678in 2025

2007: 302008: 292009: 392010: 322011: 412012: 142013: 122014: 52015: 412016: 92017: 142018: 112019: 122020: 112021: 122022: 132023: 442024: 2552025: 2,678
2007high 2,678 (2025) · low 5 (2014)2025

MAUDE reports naming product code CAD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—030
20080—029
20090—039
20100—032
20111—041
20120—014
20130—012
20140—05
20151—041
20160—09
20170—014
20181—011
20190—012
20200—011
20210—012
20220—013
20230—044
20241—5255
20250—2 (2)2,678
20260—0—

What is it indicated for?

The Sigma Delta 'T' vaporizer range is designed to attach to the back bar of an anaesthetic machine and deliver controlled concentrations of anaesthesia gasses into a fresh gas. The fresh gas is then delivered into a patient breathing system, from where the anaesthesia ventilator and breathing circuit will then deliver this fresh gas mixture to the patient.

The Vaporizer is calibrated in Vol % of the fresh gas flow and is compensated for changes in both fresh gas flows and temperature changes within the specified range.

The indicated use of the Sigma Delta 'T' has therefore not changed from that of the legally marketed device the Sigma Delta.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K041076: Delta T.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K041076

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026